Hikma Pharmaceuticals
HIK.L
#3618
Rank
A$5.14 B
Marketcap
A$23.61
Share price
-2.07%
Change (1 day)
-42.13%
Change (1 year)

Half-year Reports

Thumbnail Hikma Pharmaceuticals
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2018-h1

Half-year Report 2018-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2017-h1

Half-year Report 2017-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2016-h1

Half-year Report 2016-h1

Language: English

View Half-year Report
Thumbnail Hikma Pharmaceuticals
 Half-year Report 2015-h1

Half-year Report 2015-h1

Language: English

View Half-year Report